Table 6.
Beta | SE | Wald | OR | Lower | Upper | p-Value | |
---|---|---|---|---|---|---|---|
Clavien–Dindo ≥ 3 | |||||||
MILS | −1.72 | 0.57 | 9.23 | 0.18 | 0.06 | 0.54 | 0.002 |
High PPT-ALT on POD 1 | 0.99 | 0.51 | 3.84 | 2.69 | 1.01 | 7.24 | 0.049 |
Re-intervention | |||||||
High PPT-ALT on POD 1 | 2.88 | 0.98 | 8.66 | 17.81 | 2.62 | 121.31 | 0.003 |
Benign disease | 2.23 | 0.87 | 6.60 | 9.32 | 1.70 | 51.10 | 0.01 |
Cholangiocellular cancer | 2.62 | 1.18 | 4.98 | 13.77 | 1.38 | 137.89 | 0.03 |
Age, yr | 0.07 | 0.03 | 4.59 | 1.08 | 1.01 | 1.15 | 0.03 |
Prolonged postoperative stay (>10 days) | |||||||
MILS | −2.99 | 0.78 | 14.87 | 0.05 | 0.01 | 0.23 | <0.001 |
Duration of surgery | 0.004 | 0.002 | 5.60 | 1.00 | 1.001 | 1.01 | 0.02 |
PPT: postoperative peak transaminase; MILS: minimally invasive liver surgery.